Miller-Rich Nancy — SEC Form 4 filings
SEC reporting owner CIK 1735084. 7 Form 4 filings on record with FilingPulse; latest filed 2026-06-18.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-05-23 to 2026-06-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 1 filing — 922 shares, $10,447 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: purchase of 413 shares @ $12.81 ($5,291) in Aldeyra Therapeutics, Inc., filed 2024-10-21.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Aldeyra Therapeutics, Inc. (ALDX) | Director | 4 | 2 legs · 922 sh · $10,447 | — | 6 |
| 4D Molecular Therapeutics, Inc. (FDMT) | Director | 3 | — | — | 3 |
Form 4 filings — Miller-Rich Nancy
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-18 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Aldeyra Therapeutics, Inc. (ALDX) | Grant/award (A): 70,000 (derivative) @ $0 · Grant/award (A): 3,318 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Grant/award (A): 22,500 (derivative) @ $0 | EDGAR |
| 2025-06-12 | 4 | Aldeyra Therapeutics, Inc. (ALDX) | Grant/award (A): 62,728 (derivative) @ $0 · Grant/award (A): 2,413 (derivative) @ $0 | EDGAR |
| 2024-10-21 | 4 | Aldeyra Therapeutics, Inc. (ALDX) | Purchase (P): 413 @ $12.81 · Purchase (P): 509 @ $10.13 | EDGAR |
| 2024-06-06 | 4 | Aldeyra Therapeutics, Inc. (ALDX) | Grant/award (A): 40,282 (derivative) @ $0 · Grant/award (A): 1,736 (derivative) @ $0 | EDGAR |
| 2024-05-23 | 4 | 4D Molecular Therapeutics, Inc. (FDMT) | Grant/award (A): 22,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1735084 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →